# 1. Target: GSR
6 regulons containing the target(s), GSR are overactive in this patient.
None
# 1. Target: FNTA,FNTB
15 regulons containing the target(s), FNTA,FNTB are overactive in this patient.
2 regulons containing the target(s), ALDH2 are overactive in this patient.
None
No additional evidence was found
24 regulons containing the target(s), JAK1,JAK2 are overactive in this patient.
None
No additional evidence was found
# 1. Target: KCNK3
2 regulons containing the target(s), KCNK3 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
3 regulons containing the target(s), SLC6A1 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
4 regulons containing the target(s), ADORA1 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
20 regulons containing the target(s), JAK2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
4 regulons containing the target(s), JAK1 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ABL1 are overactive in this patient.
No glioblastoma clinical trials were found for these drugs.
24 regulons containing the target(s), JAK1,JAK2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
3 regulons containing the target(s), RTN4 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
15 regulons containing the target(s), FNTA,FNTB are overactive in this patient.
20 regulons containing the target(s), MAPK1,MAPK3 are overactive in this patient.
None
No additional evidence was found
1 regulons containing the target(s), BACE1 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), NDUFA13 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), TSG101 are overactive in this patient.
HALLMARK_OXIDATIVE_PHOSPHORYLATION HALLMARK_DNA_REPAIR HALLMARK_MYC_TARGETS_V1
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), VAMP2 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
2 regulons containing the target(s), NQO1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
1 regulons containing the target(s), TRPV4 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
29 regulons containing the target(s), HSPA8 are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
16 regulons containing the target(s), ABAT are overactive in this patient.
None
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
6 regulons containing the target(s), GSR are overactive in this patient.
None
No glioblastoma clinical trials were found for these drugs.
63 regulons containing the target(s), ATP1A1 are overactive in this patient.
HALLMARK_UV_RESPONSE_DN HALLMARK_APOPTOSIS HALLMARK_EPITHELIAL_MESENCHYMAL_TRANSITION HALLMARK_TGF_BETA_SIGNALING HALLMARK_COMPLEMENT HALLMARK_TNFA_SIGNALING_VIA_NFKB
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), SOD1 are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
5 regulons containing the target(s), ACVR2B are overactive in this patient.
No additional evidence was found
No glioblastoma clinical trials were found for these drugs.
***Warning message: Missing column names filled in: ‘X15’ [15], ‘X16’ [16], ‘X17’ [17], ‘X18’ [18], ‘X19’ [19], ‘X20’ [20], ‘X21’ [21], ‘X22’ [22], ‘X23’ [23], ‘X24’ [24], ‘X25’ [25], ‘X26’ [26], ‘X27’ [27], ‘X28’ [28], ‘X29’ [29], ‘X30’ [30], ‘X31’ [31], ‘X32’ [32], ‘X33’ [33], ‘X34’ [34], ‘X35’ [35], ‘X36’ [36], ‘X37’ [37], ‘X38’ [38], ‘X39’ [39], ‘X40’ [40], ‘X41’ [41], ‘X42’ [42], ‘X43’ [43], ‘X44’ [44], ‘X45’ [45], ‘X46’ [46], ‘X47’ [47], ‘X48’ [48], ‘X49’ [49], ‘X50’ [50], ‘X51’ [51], ‘X52’ [52], ‘X53’ [53], ‘X54’ [54], ‘X55’ [55], ‘X56’ [56], ‘X57’ [57], ‘X58’ [58], ‘X59’ [59], ‘X60’ [60], ‘X61’ [61], ‘X62’ [62], ‘X63’ [63], ‘X64’ [64], ‘X65’ [65], ‘X66’ [66], ‘X67’ [67], ‘X68’ [68], ‘X69’ [69], ‘X70’ [70], ‘X71’ [71], ‘X72’ [72], ‘X73’ [73], ‘X74’ [74], ‘X75’ [75], ‘X76’ [76], ‘X77’ [77], ‘X78’ [78], ‘X79’ [79], ‘X80’ [80], ‘X81’ [81], ‘X82’ [82], ‘X83’ [83], ‘X84’ [84], ‘X85’ [85], ‘X86’ [86], ‘X87’ [87], ‘X88’ [88], ‘X89’ [89], ‘X90’ [90], ‘X91’ [91], ‘X92’ [92], ‘X93’ [93], ‘X94’ [94], ‘X95’ [9 [… truncated]